Critical Diagnostics Gains China Approval for Heart Risk Assay

Critical Diagnostics, a San Diego diagnostics company, received CFDA approval for China marketing of its Presage ST2 Assay as a risk predictor in patients who have suffered heart failure. ST2 is a soluble protein that is expressed following heart disease or injury, reflecting ventricular remodeling and cardiac fibrosis. Patients whose assays record high scores are at greater risk for death or heart transplants. More details.... Share this with colleagues: // //